Overview

Effects of Paclitaxel on Intimal Hyperplasia

Status:
Completed

Trial end date:
2015-04-01

Target enrollment:

Participant gender:

Summary

This is a single, one time, limited dose infusion of Paclitaxel, that will potentially prevent recurrent stenosis secondary to intimal hyperplasia when compared to the control group at 10 months.

Phase:

N/A

Details

Lead Sponsor:

Patrick Kelly

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel